UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database

Gynecologic oncology, 2019-02, Vol.152 (2), p.361-367

2019

Volltextzugriff (PDF)

Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia

Gynecologic oncology, 2016-12, Vol.143 (3), p.565-570

2016

Volltextzugriff (PDF)

The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid

European journal of cancer (1990), 2013-10, Vol.49 (15), p.3184-3190

2013

Volltextzugriff (PDF)

A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom

Gynecologic oncology, 2015-02, Vol.136 (2), p.258-263

2015

Volltextzugriff (PDF)

Classification systems in Gestational trophoblastic neoplasia - Sentiment or evidenced based?

Cancer treatment reviews, 2017-05, Vol.56, p.47-57

2017

Volltextzugriff (PDF)

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

Journal of clinical oncology, 2004-01, Vol.22 (1), p.53-61

2004

Volltextzugriff (PDF)

Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment

Journal of clinical oncology, 2000-02, Vol.18 (3), p.498-509

2000

Volltextzugriff (PDF)

Prognostic factors for renal cell carcinoma

Cancer treatment reviews, 2008-08, Vol.34 (5), p.407-426

2008

Volltextzugriff (PDF)

The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease

Gynecologic oncology, 2004-12, Vol.95 (3), p.423-429

2004

Volltextzugriff (PDF)

Diagnostic challenges in extrauterine epitheloid trophoblastic tumours: A report of two cases

Gynecologic oncology, 2008-02, Vol.108 (2), p.452-454

2008

Volltextzugriff (PDF)

Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia

Gynecologic oncology, 2009-06, Vol.113 (3), p.306-311

2009

Volltextzugriff (PDF)

The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia

European journal of cancer (1990), 2019-03, Vol.109, p.162-171

2019

Volltextzugriff (PDF)

The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?

Oncology letters, 2010-01, Vol.1 (1), p.187-188

2010

Volltextzugriff (PDF)

Is there a relationship between treatment for infertility and gestational trophoblastic disease?

Human reproduction (Oxford), 2004-02, Vol.19 (2), p.365-367

2004

Volltextzugriff (PDF)

LBA56 - Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

Annals of oncology, 2019-10, Vol.30, p.v891-v892

2019

Volltextzugriff (PDF)

Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

Annals of oncology, 2019-10, Vol.30, p.v891-v892

2019

Volltextzugriff (PDF)

A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease

International journal of gynecological cancer, 2000-07, Vol.10 (4), p.318-322

2000

Volltextzugriff (PDF)

Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?

European journal of obstetrics & gynecology and reproductive biology, 2019-03, Vol.234, p.117-119

2019

Volltextzugriff (PDF)

Gender differences in self-reported late effects, quality of life and satisfaction with clinic in survivors of lymphoma

Psycho-oncology (Chichester, England), 2011-11, Vol.20 (11), p.1202-1210

2011

Volltextzugriff (PDF)

PII: S0090-8258(05)00648-7

Gynecologic oncology, 2005, Vol.99 (1), p.252-253

2005

Volltextzugriff (PDF)

P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significance

European journal of cancer (1990), 1994, Vol.30 (11), p.1701-1704

1994

Volltextzugriff (PDF)

Gestational trophoblastic disease in the Asian population of Northern England and North Wales

BJOG : an international journal of obstetrics and gynaecology, 2003-06, Vol.110 (6), p.555-559

2003

Volltextzugriff (PDF)

Gestational trophoblastic disease in the Asian population of Northern England and North Wales

BJOG : an international journal of obstetrics and gynaecology, 2003-06, Vol.110 (6), p.555-559

2003

Volltextzugriff (PDF)

Adjuvant therapy of malignant melanoma

Critical reviews in oncology/hematology, 2002-10, Vol.44 (1), p.81-102

2002

Volltextzugriff (PDF)

Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)

Annals of oncology, 2010-03, Vol.21 (3), p.568-573

2010

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(87)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(55)
Humans
(52)
Oncology
(39)
Female
(32)
Adult
(29)
Biological And Medical Sciences
(28)
Medical Sciences
(24)
Middle Aged
(20)
Male
(18)
Adolescent
(14)
Obstetrics & Gynecology
(12)
Hematologic And Hematopoietic Diseases
(11)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(11)
Pregnancy
(11)
Prognosis
(11)
Chemotherapy
(10)
Retrospective Studies
(10)
Combined Modality Therapy
(9)
Aged
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database

Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia

The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid

A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom

Classification systems in Gestational trophoblastic neoplasia - Sentiment or evidenced based?

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment

Prognostic factors for renal cell carcinoma

The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease

Diagnostic challenges in extrauterine epitheloid trophoblastic tumours: A report of two cases

Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia

The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia

The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?

Is there a relationship between treatment for infertility and gestational trophoblastic disease?

LBA56 - Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease

Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?

Gender differences in self-reported late effects, quality of life and satisfaction with clinic in survivors of lymphoma

PII: S0090-8258(05)00648-7

P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significance

Gestational trophoblastic disease in the Asian population of Northern England and North Wales

Gestational trophoblastic disease in the Asian population of Northern England and North Wales

Adjuvant therapy of malignant melanoma

Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)

Suchergebnisse filtern